This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content (V体育ios版)

Add to Collections

Your saved search

Name of saved search: \/]*" title="The following characters are not allowed in the Name field: "&=<>/">

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

V体育安卓版 - Full text links

Elsevier Science

Full text links

Actions

. 2019 Feb 11;35(2):177-190.e8.

doi: 10.1016/j.ccell.2018.12.009. Epub 2019 Jan 24.

Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers

Affiliations

V体育2025版 - Affiliations

¹ Division of Genome Biology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Electronic address: hogiwara@qiuluzeuv.cn.
² Division of Genome Biology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan.
³ Division of Genome Biology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; Molecular Oncology, The Jikei University Graduate School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan.
⁴ Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
⁵ Tsuruoka Metabolomics Laboratory, National Cancer Center, Tsuruoka, Yamagata 997-0052, Japan; Shonai Regional Industry Promotion Center, Tsuruoka, Yamagata 997-0015, Japan.
⁶ Tsuruoka Metabolomics Laboratory, National Cancer Center, Tsuruoka, Yamagata 997-0052, Japan.
⁷ Department of Translational Oncology, Fundamental Innovative Oncology Core Center, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
⁸ Department of Gynecology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
⁹ Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan.
¹⁰ Division of Genome Biology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; Molecular Oncology, The Jikei University Graduate School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan. Electronic address: tkkohno@qiuluzeuv.cn.

PMID: 30686770
DOI: 10.1016/j.ccell.2018.12.009

Free article

"V体育2025版" Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers

Hideaki Ogiwara (V体育2025版) et al. Cancer Cell. 2019.

Free article

. 2019 Feb 11;35(2):177-190.e8.

doi: 10.1016/j.ccell.2018.12.009. Epub 2019 Jan 24.

V体育官网 - Authors

Affiliations

¹ Division of Genome Biology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Electronic address: hogiwara@qiuluzeuv.cn.
² Division of Genome Biology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan.
³ Division of Genome Biology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; Molecular Oncology, The Jikei University Graduate School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan.
⁴ Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
⁵ Tsuruoka Metabolomics Laboratory, National Cancer Center, Tsuruoka, Yamagata 997-0052, Japan; Shonai Regional Industry Promotion Center, Tsuruoka, Yamagata 997-0015, Japan.
⁶ Tsuruoka Metabolomics Laboratory, National Cancer Center, Tsuruoka, Yamagata 997-0052, Japan.
⁷ Department of Translational Oncology, Fundamental Innovative Oncology Core Center, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
⁸ Department of Gynecology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
⁹ Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan.
¹⁰ Division of Genome Biology, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; Molecular Oncology, The Jikei University Graduate School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan. Electronic address: tkkohno@qiuluzeuv.cn.

PMID: 30686770
DOI: "VSports注册入口" 10.1016/j.ccell.2018.12.009

Abstract

ARID1A encodes an SWI/SNF chromatin-remodeling factor and is frequently mutated in various cancers. This study demonstrates that ARID1A-deficient cancer cells are specifically vulnerable to inhibition of the antioxidant glutathione (GSH) and the glutamate-cysteine ligase synthetase catalytic subunit (GCLC), a rate-limiting enzyme for GSH synthesis. Inhibition of GCLC markedly decreased GSH in ARID1A-deficient cancer cells, leading to apoptotic cell death triggered by excessive amounts of reactive oxygen species. The vulnerability of ARID1A-deficient cancer cells results from low basal levels of GSH due to impaired expression of SLC7A11. The SLC7A11-encoded cystine transporter supplies cells with cysteine, a key source of GSH, and its expression is enhanced by ARID1A-mediated chromatin remodeling. Thus, ARID1A-deficient cancers are susceptible to synthetic lethal targeting of GCLC VSports手机版. .

Keywords: APR-246; ARID1A; GCLC; SWI/SNF chromatin-remodeling complex; glutathione; ovarian cancer; ovarian clear cell carcinoma; reactive oxygen species; synthetic lethality; vulnerability V体育安卓版. .

Copyright © 2018 Elsevier Inc. All rights reserved. V体育ios版.

PubMed Disclaimer

Comment in

VSports - Glutathione Metabolism: An Achilles' Heel of ARID1A-Deficient Tumors.
Gorrini C, Mak TW. Gorrini C, et al. Cancer Cell. 2019 Feb 11;35(2):161-163. doi: 10.1016/j.ccell.2019.01.017. Cancer Cell. 2019. PMID: 30753819

Publication types (V体育官网)

Actions

"VSports最新版本" MeSH terms

Actions (VSports最新版本)
V体育2025版 - Actions
Actions
Actions
VSports在线直播 - Actions
Actions
V体育ios版 - Actions
"VSports app下载" Actions
Actions
Actions
V体育官网入口 - Actions
Actions
Actions
V体育平台登录 - Actions
Actions
V体育安卓版 - Actions
Actions
Actions
Actions
"V体育官网入口" Actions
Actions
Actions (V体育平台登录)
Actions
Actions (V体育2025版)
Actions
Actions
Actions
"VSports手机版" Actions

Substances

"V体育安卓版" Actions
"VSports在线直播" Actions
Actions (VSports)
Actions
Actions
Actions
Actions
Actions (V体育官网)
Actions
Actions
V体育官网 - Actions
Actions
Actions

VSports - LinkOut - more resources

"V体育2025版" Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
V体育安卓版 - Medical
- MedlinePlus Health Information
Molecular Biology Databases
- NIAID Data Ecosystem - Find datasets on Infectious and Immune-mediated Diseases
Research Materials
"V体育平台登录" Miscellaneous
- NCI CPTAC Assay Portal